ReviewLancet (London, England)2024
The Lancet Commission on prostate cancer: planning for the surge in cases.
Erratum issuedAbstract readReview
In one paragraph
Review in Lancet (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 412 papers, 9 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
412citing papers in PubMed, 9 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
412 citing papers in PubMed, 9 syntheses or guidelines pooled it.
- Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026Pooled it
- Micro-ultrasonography- vs MRI-targeted biopsy in prostate cancer: Updated systematic review and meta-analysis.BJU international · 2026Pooled it
- Post-diagnosis physical activity in relation to mortality among prostate cancer survivors: a systematic review and meta-analysis.Cancer causes & control : CCC · 2026Pooled it
- The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review.Current oncology (Toronto, Ont.) · 2026Pooled it
- Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis-a systematic review including meta-analysis of all comparative studies.Prostate cancer and prostatic diseases · 2026Pooled it
- Peritoneal flaps for the prevention of lymphoceles after robot-assisted radical prostatectomy-a systematic review and IPD-meta-analysis of randomized controlled trials.World journal of urology · 2026Pooled it
- Association between BK polyomavirus and prostate cancer: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis.Frontiers in immunology · 2026Pooled it
- Pooled it
- Trial
- The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study.BJU international · 2026Trial
- Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial.BJU international · 2026Trial
- Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer.Journal for immunotherapy of cancer · 2026Trial
- Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial.Signal transduction and targeted therapy · 2026Trial
- Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial.JAMA oncology · 2025Trial
- Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience.Clinical and translational radiation oncology · 2027Article
- Dyadic coping, relationship quality, and psychosocial adaption between couples facing prostate cancer: A longitudinal cross-lagged study.Asia-Pacific journal of oncology nursing · 2026Article
- Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2026Article
- Combined ADC and TMagnetic resonance in medicine · 2026Article
- The molecular heterogeneity and clinical impact of genomic driver alterations in prostate cancer.Nature communications · 2026Article
352 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Erratum issued
Authors and funding
40 authors.
Nicholas D JamesInstitute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: nick.james@icr.ac.uk.
Ian TannockPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
James N'DowUniversity of Aberdeen, Aberdeen, UK.
Felix FengUniversity of California, San Francisco, USA.
Silke GillessenOncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Syed Adnan AliUniversity of Manchester, Manchester, UK; The Christie Hospital, Manchester, UK.
Blanca TrujilloUniversity College London, London, UK.
Bissan Al-LazikaniMD Anderson Cancer Centre, Houston, TX, USA.
Gerhardt AttardUniversity College London, London, UK.
Freddie BrayInternational Agency for Research on Cancer, Lyon, France.
Eva CompératTenon Hospital, Sorbonne University, Paris; AKH Medical University, Vienna, Austria.
Ros EelesInstitute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
Omolara FatiregunLagos State University Teaching Hospital, Lagos, Nigeria.
Emily GristUniversity College London, London, UK.
Susan HalabiDuke Cancer Institute, Durham, NC, USA.
Áine HaranThe Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Daniel HerchenhornLatin America Cooperative Group, Rio de Janeiro, Brazil.
Michael S HofmanPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Mohamed JallohUniversité Cheikh Anta Diop de Dakar, Dakar, Senegal.
Stacy LoebNew York University, New York, NY, USA; Manhattan Veterans Affairs, New York, NY, USA.
Archie MacNairUniversity College London, London, UK.
Brandon MahalUniversity of Miami, Miami, FL, USA.
Larissa MendesUniversity College London, London, UK.
Masood MoghulInstitute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
Caroline MooreUniversity College London, London, UK.
Alicia MorgansDana Farber Cancer Institute, Boston, MA, USA.
Michael MorrisMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Declan MurphyPeter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Vedang MurthyTata Memorial Centre, Mumbai, India.
Paul L NguyenHarvard University, Boston, MA, USA.
Anwar PadhaniMount Vernon Cancer Centre, London, UK.
Charles ParkerUniversity College London, London, UK.
Hannah RushUniversity College London, London, UK.
Mark SculpherUniversity of York, York, UK.
Howard SouleProstate Cancer Foundation, Santa Monica, CA, USA.
Matthew R SydesUniversity College London, London, UK.
Derya TilkiMartini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Türkiye.
Nina TunariuInstitute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
Paul VillantiMovember, Melbourne, VIC, Australia.
Li-Ping XieFirst Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MCancer Research UK 15007Cancer Research UK 17528Medical Research Council MC_UU_00004/01Medical Research Council MC_UU_00004/02Medical Research Council MC_UU_00004/08NCI NIH HHS P30 CA008748Wellcome TrustWorld Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Prostatic NeoplasmsHumansMale
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.